MoonLake Immunotherapeutics (MLTX) ownership: Top institutional holder: BVF INC/IL ($298.26M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BVF INC/IL | 16001284.00 | $298.26M | 2026-03-31 |
| Deep Track Capital, LP | 6408863.00 | $119.46M | 2026-03-31 |
| Cormorant Asset Management, LP | 4480433.00 | $83.52M | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 3451628.00 | $64.30M | 2026-03-31 |
| FEDERATED HERMES, INC. | 1248573.00 | $58.93M | 2025-06-30 |
| D. E. Shaw & Co., Inc. | 2390661.00 | $44.56M | 2026-03-31 |
| MPM BIOIMPACT LLC | 1811082.00 | $33.76M | 2026-03-31 |
| Weiss Asset Management LP | 1708328.00 | $31.84M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-05-11 | |
| Sell | null | 2026-05-11 | |
| Sell | null | 2026-04-14 | |
| Sell | null | 2026-04-14 | |
| Sell | null | 2026-04-13 |
Back to MLTX overview · MLTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.